Activist investor Bill Ackman warned Botox maker Allergan Inc. on Monday that it would be unwise to court potential acquirers as an alternative to the offer that he and Valeant Pharmaceuticals International Inc. have made for the company. Last month, Ackman and Valeant offered an estimated $45 billion in cash and stock for Allergan, an Irvine company that makes most of its money from Botox but also sells breast implants and a line of ophthalmic drugs. Allergan quickly implemented a "poison pill" defense to slow Ackman and Valeant's pursuit of the company and reportedly pursued other potential buyers.
Help employers find you! Check out all the jobs and post your resume.
